The objective of this proposal is to define the in vivo effectiveness of a melanoma-targeted nanoparticle for systemic therapeutic delivery. The approach is to utilize a clinically experienced fusogenic bilamellar invaginated vesicle nanoparticle (BIV NP)with a manually extruded DOTAP:cholesterol…
More